Materials & Resources » Chemicals | Boai NKY Pharmaceuticals Ltd.

Boai NKY Pharmaceuticals Ltd. | Income Statement

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
208,542.90
251,856.40
288,295.80
395,174.40
481,091.60
690,343.50
Cost of Goods Sold (COGS) incl. D&A
153,184.60
178,920.80
170,466.80
226,672.30
263,245.90
389,237.60
Gross Income
55,358.20
72,935.60
117,829.00
168,502.10
217,845.70
301,105.90
SG&A Expense
30,410.20
35,243.10
50,015.80
72,592.30
109,226.60
166,695.50
EBIT
23,544.00
35,463.50
65,124.60
93,099.90
108,612.80
132,001.20
Unusual Expense
-
520.00
375.70
-
433.20
1,373.70
Non Operating Income/Expense
1,430.50
293.10
2,187.70
1,777.90
814.90
3,906.50
Interest Expense
27.10
488.30
1,501.60
6,340.40
3,865.30
34,089.50
Pretax Income
23,345.10
35,096.80
67,039.00
96,530.00
110,502.30
101,687.10
Income Tax
3,180.10
4,979.00
10,050.70
14,321.80
15,955.90
14,734.40
Equity in Affiliates
-
-
2.60
1,984.90
1,900.90
3,628.90
Consolidated Net Income
20,165.10
30,117.90
56,985.70
80,223.30
92,645.40
90,581.60
Net Income
20,165.10
30,117.90
56,985.70
80,039.80
92,823.20
89,546.20
Net Income After Extraordinaries
20,165.10
30,117.90
56,985.70
80,039.80
92,823.20
89,546.20
Net Income Available to Common
20,165.10
30,117.90
56,985.70
80,039.80
92,823.20
89,546.20
EPS (Basic)
0.14
0.20
0.33
0.36
0.42
0.41
Basic Shares Outstanding
150,322.00
150,322.00
172,928.70
222,458.80
221,479.90
218,405.30
EPS (Diluted)
0.13
0.20
0.33
0.36
0.42
0.41
Diluted Shares Outstanding
150,322.00
150,322.00
172,928.70
222,458.80
221,479.90
218,405.30
EBITDA
33,221.80
54,769.40
89,439.50
124,968.20
145,021.60
172,947.60
Other Operating Expense
1,404.10
2,229.10
2,688.70
2,809.90
6.40
2,409.30
Non-Operating Interest Income
93.60
42.00
451.10
7,992.60
4,174.70
927.10
Minority Interest Expense
-
-
-
183.50
177.80
1,035.40

About Boai NKY Pharmaceuticals

View Profile
Address
No. 1888 Wenhua (East Section) Road
Jiaozuo Henan 454450
China
Employees -
Website http://www.boai-nky.com
Updated 07/08/2019
NKY Medical Holdings Ltd. engages in the manufacture of polymers for pharmaceuticals, personal care and household industries. Its products include KoVidone K, PolyKoVidone, KoVidone I, KoVidone VA64, OraRez, PVM/MA-AN, PVM/MA-Diacid, PVM/MA-MS, WhiVidone. The company was founded on March 13, 2003 and is headquartered in Jiaozuo, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.